ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver failure"

  • 2017 American Transplant Congress

    Molecular Adsorbent Recirculating System (MARS) Effectively Replaces Hepatic Function in Severe Acute Liver Failure.

    S. Hanish,1 R. Barth,1 D. Stein,2 E.-O. Essien,1 P. Thurman,2 T. Scalea,2 S. Bartlett.1

    1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 2R Adams Cowley Shock Trauma Center, Baltimore, MD

    Introduction:Patients with severe ALF have extreme physiologic dysfunction and often die if transplantation is not immediately available. Patients may be supported with MARS (R, Gambro)…
  • 2017 American Transplant Congress

    Inflammation, Impaired Energy Metabolism and Synthetic Failure Characterize the Liver Transcriptome of End-Stage Idiopathic Pediatric Acute Liver Failure (PALF).

    M. Ningappa,1 P. McKiernan,2 R. Squires,2 Q. Sun,1 B. Higgs,1 K. Soltys,1 G. Bond,1 C. Ashokkumar,1 G. Mazariegos,1 R. Sindhi.1

    1Pediatric Abdominal Surgery, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; 2Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA

    Background: PALF requiring liver transplantation (LTx) often has no known etiology, and could result from undiagnosed metabolic disorders. Mitochondrial dysfunction is common in PALF, but…
  • 2017 American Transplant Congress

    Development and Validation of an FLF-Transplant Score to Predict Mortality of Patients with Fulminant Liver Failure.

    Z. Guo, B. Chen, X. He, G. Chen.

    The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    BACKGROUND & AIMS: We aimed to develop a simple prognostic model in predicting fulminant liver failure (FLF) patient mortality within 14 days after being listed…
  • 2017 American Transplant Congress

    Liver Transplantation Beyond MELD 40.

    J. Scalea, D. Bruno, S. Hanish, J. Lamattina, J. Alvarez-Casas, S. Malik, A. Cimeno, S. Bartlett, R. Barth.

    Surgery, University of Maryland, Baltimore, MD

    OBJECTIVE(S): Liver allocation is prioritized for the sickest patients; however, poorer liver transplant (LTx) outcomes are associated with increasing MELD scores. While MELD is capped…
  • 2017 American Transplant Congress

    Simultaneous or Sequential Heart-Liver Transplantation Confer Superior Survival in Patients with Listed for Heart-Liver Transplantation: A National Analysis.

    K. Anderson,1 M. Mulvihill,2 B. Yerokun,2 A. Barbas,2 M. Hartwig.2

    1Duke School of Medicine, Durham, NC; 2Dept of Surgery, Duke University Medical Center, Durham, NC

    Background: Simultaneous heart-liver transplantation (TXP), for patients with combined heart and liver failure, confers survival benefit over remaining on the waitlist. Whether heart TXP followed…
  • 2017 American Transplant Congress

    Substance Abuse in Acute Liver Failure: Time to Talk About Opiates.

    M. Jesse, N. Rebhan, A. Yoshida, D. Moonka, A. Eshelman, M. Abouljoud, M. Rizzari.

    Transplant Institute, Henry Ford Health System, Detroit

    Purpose: Prescription opiate utilization is on the rise. Research on acute liver failure (ALF) has focused on acetaminophen (APAP) overdose or other medical etiologies but…
  • 2017 American Transplant Congress

    Liver Retransplantation: The Largest Post MELD Single Center Experience.

    F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.

    Surgery, University of California Los Angeles, Los Angeles, CA

    OBJECTIVE: Analyze post MELD liver retransplantation (Re-OLT) and identify recipient and donor preoperative risk factors associated with poor patient outcomes.BACKGROUND: Re-OLT is a high risk…
  • 2017 American Transplant Congress

    Enhanced Liver Regeneration After Partial Hepatectomy in Mice Treated with a Prolyl Hydroxylase Inhibitor.

    J. Latona,1 A. Shah,1 J. Cheng,2 P. Messersmith,2 E. Heber-Katz.3

    1Thomas Jefferson University, Philadelphia, PA; 2University of California, Berkeley, Berkeley, CA; 3Lankenau Institute for Medical Research, Wynnewood, PA

    Purpose: Resection of more than 70% of liver mass increases incidence of post-operative hepatic failure due to an inability of the liver remnant to adequately…
  • 2017 American Transplant Congress

    Liver Regeneration in Porcine Hepatectomy Model.

    H. Chen, D. Joo, M. Shaheen, J. Yang, S. Nyberg.

    Department of Transplantation Surgery, Mayo Clinic, Rochester, MN

    Background: Acute Liver Failure (ALF) is a serious condition. A substantial number of donor livers (10%) are used to save ALF patients. Supportive therapies such…
  • 2016 American Transplant Congress

    High Efficacy of Ledipasvir/Sofosbuvir with Ribavirin in HCV Genotype-1 Infected Patients with Decompensated Liver Disease: Analysis by MELD Score from the SOLAR-1 and SOLAR-2 Trials.

    M. Charlton,1 E. Yoshida,2 M. Bouliere,3 S. Flamm,4 A. Muir,5 M. Fried,6 N. Terrault,7 S. Arterburn,8 C. Yun,8 P. Pang,8 A. Osinusi,8 J. Spellman,8 M. Natha,8 D. Brainard,8 J. McHutchison,8 M. Manns,9 N. Afdhal.10

    1Intermountain Medical Center, Salt Lake City; 2Vancouver General Hospital, Vancouver, Canada; 3Hopital Saint Joseph, Marseilles, France; 4Northwestern University, Chicago; 5Duke University, Durham; 6University of North Carolina, Chapel Hill; 7UCSF, SF; 8Gilead Sciences Inc, Foster City; 9Hannover Medical School, Hannover, Germany; 10BIDMC, Boston.

    Introduction: HCV infected patients with decompensated liver disease have significant morbidity & mortality. The efficacy & safety of LDV/SOF + RBV was evaluated in a…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences